580
1395584226014562114171
Ces36997936014570127174
Urol38987936014578115180208
2024;41317936014562121178235258
28(3):44147936014562121154212241263
133–14047037936014561113170231284338400
PŘEHLEDOVÉ3674207016974156235334409485586692777855
ČLÁNKY4576207016981154252352436525
ZÁVĚR625858018183179257334416
Dostupná6241198013170127165198253311367414
data10551198013159106136183
potvrzují12561198013160117147197228272328349369
nízké,1642119801315878120164213228
ale1888119801314969120
reálné2025119801313282128148203254
riziko229711980131325294115158213
ovliv‑25271198013158104125145192223
nění6241348013160112170190
kognitivního8451348013147104164221242275296345404425485543
výkonu14181348013150102148205263320
a17681348013151
rozvoje1849134801313389131184240262314
demence21941348013160113202255312361411
při2636134801316192114
dlouhodobé297689801316081139196253311370428487541
expozici3547898013154100160219260282329350
anticholinergikům3927898013151108139160207264322344365422474505562583627685773
používa‑4730898013161120177220242290339372
ným29761048013159104193
v31901048013150
léčbě3261104801312375123181234
OAB.35161048013174133186204
Vždy3741104801315699156203
bychom39651048013161107153210267355
proto4341104801316192147179234
měli45961048013190142163183
pečlivě48001048013161114162183203251302
zvažovat2976119801314495143186240286334365
poměr33581198013160118205256286
mezi36611198013190141184205
očekávaným38831198013158106154198247293341397441529
benefitem44291198013161113169220244270302351438
a48841198013150
po‑49511198013160118151
tenciálními2976134801313484141188209256277333354442462
riziky346013480131335497118163213
v36951348013150
případě3767134801316091112171219278329
konkrétního41181348013147103160204237287319376397456513
pacienta.46531348013160109157177229286316365383
LITERATURA625178401475992157220291371428510580661
1.624194601335673
Fox7261946013354113162
C,917194601336388
Richardson1033194601335985134194247282343386446507
K,1569194601335985
Maidment16831946013388141166228319374435470
ID,2182194601332699118
et2329194601335591
al.2449194601335378101
Anticholinergic25791948013164122154176225282340364385443496527585607655
medication32641948013190143203225273323355377435494
use3787194801315998151
and39681948013150108167
cognitive41651948013149105165223244278300349401
impairment45961948013123111171221243274364417475507
in624209801312381
the731209801313492145
older902209801315982141194225
population:11542098013160120180238260309341363421479496
the1676209801313492146
medical18482098013190143203225273323345
research2220209801313284124177225256303361
council26072098013149105163221269291313
cognitive29462098013149105166223245278301350402
function3374209801312988145194230252310368
and37692098013150107167
ageing39622098013150110162184242301
study.4290209801314175133192241254
J45702098013138
Am46342098013165154
Geriatr48142098013169123154177225257289
Soc.6242248013151109159178
2011;8262248013154105153194204
59(8):10542248013154102131181208225
1477–1483.13032248013153100148200249295342396448465
2.624239601335679
Haylen7342396013372125175201256317
BT,10822396013359114130
de12432396013362117
Ridder1391239601335985146208263299
D,1721239601337392
Freeman1845239601335386140196287340400
RM,22762396013359148172
et2479239601335591
al.2601239601335379101
An27342398013164122
International2888239801312481113164196254303335357415474522544
Urogynecological34642398013169100157217265325378427483506564624646694744766
Association42622398013165107147205254276324356379436495
(IUGA)/4789239801312951118186250278314
International624254801312381113163195253302334356414472521543
Continence11872548013163119177209231289342399448499
Society17062548013151109159180233266317
(ICS)2043254801312951113165192
joint2256254801312381103161192
report2469254801313284143202234271
on27612548013158116
the2898254801313492145
terminology3063254801313485116206228285343366424485533
for3616254801312986118
female3755254801312880169218240293
pelvic40682548013161115137186209257
floor4346254801312653111170202
dysfunction.45682548013160108148178237294343379401459517535
Int624269801312381113
Urogynecol761269801316999156216265324377426482506
J.1291269801313855
2010;13702698013154105153200219
21(1):16132698013153101122169190206
5–26.18432698013154109157207226
3.624284601335677
Peyronnet7212846013358110161197256317376431467
B,1207284601336082
Mironska13082846013388114149208268310361414
E,1741284601335477
Chapple18372846013364123175236298324379
C,2235284601336387
et2342284601335591
al.2452284601335378100
A25722848013164
Comprehensive26562848013162118207266298349407459517556577626677
Review33532848013155108156179231309
of3682284801315887
Overactive37892848013173123175206255304340361410462
Bladder4271284801315577126185244296327
Pathophys‑46182848013155103135192250310368414454485
iology:624299801312381104162222271290
On9382998013174133
the1095299801313492145
Way12642998013190137184
to1472299801313490
Tailored1586299801315193114136194226278338
Treatment.1948299801315176128176208297350408440459
Eur24312998013151107138
Urol.25932998013169100156179198
2019;28152998013154105153198216
75(6):30552998013154103129179205222
988–1000.33012998013154107160217263310365420438
4.624314601335679
Nambiar7243146013372125216278304356391
AK,11373146013367125151
Arlandis13093146013368103129181241303328371
S,1701314601335477
Bø17993146013360121
K,1941314601335985
et2047314601335592
al.2160314601335378101
European22823148013151107138194255309357414
Association27183148013165107147205254276324356379436495
of3235314801315887
Urology3344314801316999156179237297346
Guidelines37123148013168126148207260283304362415455
on41893148013159117
the4328314801313492145
Diagnosis4495314801317194142202259318358379418
and49353148013150108167
Management6243298013186135193241301354443496554586
of1235329801315886
Female13463298013151103192241263316
Non-neurogenic16873298013170128187220279333390421478538591649670719
Lower24313298013149106184236267
Urinary27233298013169100123180229260312
Tract3060329801315176126174211
Symptoms.3296329801315195186245278334423463482
Part38033298013156104135172
1:4000329801315465
Diagnostics,4090329801317193142201259317357392414462504522
Overactive46373298013174125177208258307343365414466
Bladder,624344801315678127186246299330343
Stress991344801315283114166206246
Urinary12613448013169100122180229260312
Incontinence,1597344801312381129185244276298355408466515566582
and22033448013150108168
Mixed23953448013185108154206266
Urinary26853448013169100122180229260312
Incontinence.3021344801312381130185244276298355408466515566583
Eur36283448013151107138
Urol.37903448013169100156179198
2022;40123448013153105154207225
82(1):42613448013153104129177197214
49–59.44993448013153103161212260276
5.624359601335677
He7213596013372127
W,8683596013392110
Huang9983596013371131184244305
G,1323359601337194
Cui14373596013364122147
W,16033596013393111
et1733359601335592
al.1844359601335379101
Comparative19653598013163119208267317348398430452501553
assessment2539359801314989129182222261350403461492
of3052359801315886
efficacy3159359801315380108136184234282333
and35133598013149107166
safety3700359801314191119171204255
of3975359801315987
approved40823598013150109170201258306358418
oral4520359801315991140163
therapies4703359801313492145176226285308360400
for624374801312985117
overactive7613748013159106158189239287323344393445
bladder:1226374801316083131190249302333353
a15993748013149
systematic1669374801314089130164214303351383405453
review2142374801313283132154207284
and24473748013149107166
network26333748013158111144225282314359
meta-analysis.30123748013190143176225258306364412434481522543581601
Int3633374801312380112
Braz3765374801315586136180
J39653748013138
Urol.4023374801316999155178196
2023;42393748013154105154206222
49(5):44813748013154103131181208224
535–563.47263748013153102152206257309360377
6.624389601335679
Herbison7223896013372127163225250292353413
P,1155389601335867
McKenzie12423896013388137195249309356381436
JE.1697389601334195118
Which18353898013190149170218276
anticholinergic21313898013150107139161209267325348369426479510568590638
is2789389801312362
best28713898013160114154188
for3080389801312885117
people32173898013161115173233256309
with35463898013179102135193
overactive37593898013158106158189239287323345394446
bladders?4225389801316184132191250303334375411
A46573898013164
network47413898013159112145226283315361
meta-analysis.6244048013190143176226259308366415437485525547586605
Neurourol12534048013170124181212269327358415438
Urodyn.1715404801316999156216265324343
2019;20824048013153105153198216
38(2):23224048013154106134185211228
525–534.25744048013154104156212263313367384
7.624419601335668
Kessler7174196013359113156198223278314
TM,10564196013354142166
Bachmann12474196013359112161221312365425485
LM,17574196013352140164
Minder19464196013389114175236291327
C,2298419601336488
et2410419601335692
al.2527419601335378101
Adverse26534198013164123172224255296349
event30284198013153102154212243
assessment3297419801315090129182223262351404462494
of3816419801315987
antimuscarinics39294198013150108139161250307347395445476499556578626668
for4623419801312886118
treating4766419801313466117165198220277337
overactive6244348013159107159190240289325347396448
bladder:1096434801316184132192251304336355
a14764348013149
network15504348013159112145226284316362
meta-analytic19364348013190143176226259308366415437485522544592
approach.25524348013150110170202259309357415434
PLoS30104348013155102159207
One.32414348013174133186203
201134684348013154105153194
Feb36864348013151102162
23;38724348013153106122
6(2):4018434801315482133159176
e16718.4218434801315397144194242289308
8.624449601335679
Kim722449601335985175
YJ,916449601335992113
Tae1048449601335499153
BS,12204496013359111133
Bae13724496013360112166
JH.15574496013341112135
Cognitive17114498013162118177234255288310358409
Function21404498013151105162210245267324382
and25424498013149106165
Urologic2727449801316898154177234293315362
Medications31094498013185137197218266315347368425483522
for3650449801312985117
Lower37874498013148104182233264
Urinary4071449801316898121177225256307
Tract4398449801315175124172208
Symptoms.4625449801315195184243275331419458477
Int624464801312381113
Neurourol7614648013170123181212268326358414437
J.1222464801313856
2020;13024648013154105155206225
24(3):15514648013153101130181205222
231–240.17974648013154107153202250297352370
9.624479601335675
Morley7244796013388149185211266316
JE,1065479601334195117
Morris12074796013388149185221246289
JC,15204796013341105129
Berg-Weger16744796013359115150211246338390452507543
M,22414796013389113
et2378479601335592
al.2494479601335379101
Brain2620479801315687137159216
health:28624798013159112160182215273290
the3178479801313492145
importance33484798013123112172231263300349407456507
of3880479801315987
recognizing3992479801313384134190250308330373396454513
cognitive45304798013149105166223245278300350402
im‑49574798013123112145
pairment:6244948013161111132164254307365396416
an10644948013150108
IAGG1196494801312385151219
consensus14394948013149105163203256314353409449
conference.19124948013149105163191243274326384433483500
J24374948013138
Am24994948013164153
Med26764948013186139199
Dir2899494801317294125
Assoc.30484948013165107147205254273
2015;33454948013154106153198213
16(9):35824948013154100128177203220
731–739.38264948013154105152201248300350366
10.6245096013356107129
Rajan7735096013359112137190250
KB,10435096013359120142
Weuve12055096013393145205258312
J,1536509601334162
Barnes16185096013360113148209264307
LL,19455096013352103126
Wilson20915096013393119144187247308
RS,24195096013359113136
Evans25755096013354105158218261
DA.28565096013373137162
Prevalence3038509801315586137186236258311369417468
and35265098013150108168
incidence3714509801312381129151210263321369420
of4155509801315887
clinically426250980131497193150172220270292314362
diagnosed4644509801316082130189247305345398459
Alzheimer’s624524801316486129187240261349401432453489
disease1133524801316081120172220259311
dementia14645248013160112200253310341363411
from1895524801312861117205
19942120524801315498151205
to2345524801313489
201224545248013153104151195
in2669524801312380
a27695248013149
population28385248013161119179236258306338359417474
study.3332524801314175132191239252
Alzheimers3603524801316486129187240261349402433473
Dement.40965248013171124212265322353372
2019;44885248013153104151196213
15(1):4721524801315498123170190206
1–7.49475248013153102149156
11.6245396013356101118
Plassman762539601335983135178221311364424
BL,12065396013360112135
Langa13625396013352106166227280
KM,16625396013360150174
McCammon18565396013388138202254345436497558
RJ,24345396013359103124
et2578539601335591
al.2690539601335378100
Incidence2811539801312381130151210263321370421
of3253539801315887
dementia33605398013160113202255313345367415
and37965398013150108167
cognitive39845398013149105166223245278300350402
impairment,44065398013123112172222243275365418476507526
not49535398013159117150
dementia6245548013160113202255313345367415
in1063554801312381
the1168554801313492145
United13375548013169126148181232292
States.1653554801315183132164215256275
Ann19525548013164123180
Neurol.21565548013171124181212269292310
2011;24905548013154106153194205
70(3):27195548013153103132183208224
418–426.2967554801315499146202258307358377
12.6245696013356104127
Tiwari778569601335582162215250276
P,1080569601335968
Dwivedi11755696013373155181233287350375
S,1576569601335577
Singh1680569601335479139200261
MP,19685696013388146156
Mishra21515696013388114156217252305
R,2483569601335984
Chandy25945696013363123175236298350
A.2970569601336893
Basic30905698013156105145167215
and33335698013149107167
modern35275698013190149209262293352
concepts39075698013149105163212263323355397
on43325698013158117
cholinergic44775698013149106165188209267320351409431479
re‑4984569801313284118
ceptor:6245848013149100160192248280300
A9485848013165
review.1037584801313284132155208286301
Asian13625848013164106128176234
Pac16205848013155103152
J17965848013138
Trop1858584801315176132192
Dis.2075584801317193132152
2013;22515848013154105153197213
3(5):2488584801315480131158175
413–420.2687584801315399143198255304355373
13.6245996013356102122
Lebois7635996013352104165223247288
EP,10685996013353109117
Thorn12015996013355114173207266
C,1484599601336385
Edgerton15865996013354112172225259296353412
JR,2015599601334098121
Popiolek21535996013358114174198256281334383
M,25535996013388110
Xi2680599601336286
S.2782599601335475
Muscarinic28745998013185140178225273302323379399446
receptor3337599801313282130179236267321352
subtype3706599801314195153184234292345
distribution4068599801315980117150180201258315346367423479
in4565599801312378
the4661599801313389141
central4819599801314998154184214262283
nervous6246148013158109138189243299336
system977614801314087125158207293
and12876148013149104161
relevance1465614801313281102152199246301348396
to1878614801313487
aging19826148013149106126181238
and22376148013149105162
Alzheimer’s2415614801316484126182233252338389418437472
disease.2904614801315979116166212250300316
Neuropharmacology.32376148013169120174204258316372418447534581627681702757815861873
2018;41276148013153102147192207
136(Pt4351614801315395145171222255
C):4623614801316290105
362–373.47456148013153103151200247293342358
14.6246296013356106128
Caulfield7766296013364117176202230259314340402
MP,12026296013388147156
Birdsall1382629601336085120182224278303328
NJ.17346296013373113135
International1893629801312381113164195254303335357415473522544
Union24626298013169126148206264
of2751629801315887
Pharmacology.28636298013155112160192282330379435458516576625638
XVII.35266298013160119143165184
Classification3735629801316284133173212234260286335384417439496555
of4315629801315887
muscarinic44276298013190147186235285316338396418466
ace‑4918629801315098149184
tylcholine624644801313485109157215273296317375428
receptors.1076644801313384134185244277333365406425
Pharmacol15256448013156112161192282331380436459
Rev.20086448013156109157171
1998;2203644801315499152205222
50(2):24506448013153105134185211228
279–290.27026448013154103154211258310364382
15.6246596013356104125
Brann768659601336095148207267
MR,10556596013388146171
Ellis1245659601335479104128170
J,1435659601334061
Jørgensen15156596013341101136197251312354408469
H,2003659601337194
Hill-Eubanks2117659601337196121146180236294355408468518564
D,2700659601337392
Jones28126596013340100161215258
SV.30896596013354115131
Muscarinic32406598013185142181230279310332389411459
acetylcholine3719659801314997148181232255302360418440462519571
receptor4310659801313384133183242275330362
subtypes:4692659801314197156188239300353393410
localization624674801312381131181203224268319351373431489
and11376748013150108167
structure/function.1329674801314175107165214250308339390430458517575623659682739798817
Prog2170674801315585142202
Brain2396674801315687137159217
Res.26376748013155108149168
1993;2829674801315499153202218
98:30716748013154107124
121–127.3219674801315498145195241286335342
16.6246896013356106128
Messer7726896013387142185227281317
WS11086896013392145
Jr,127268960133417692
Bohnett13846896013359119179239293329367
M,17716896013387111
Stibbe1901689601335488112173235290
J.2210689601334162
Evidence2292689801315198121179232289337387
for2699689801312985117
a28366898013149
preferential2905689801316192143171222253304362393415462484
involvement3409689801312380127183206254305394446504535
of3964689801315886
M140706898013185131
muscarinic42216898013189146185233282313335392413461
receptors4702689801313283132183242274329361401
in624704801312381
representational729704801313284143175227267320378410459492514571630679701
memory.14547048013190143232291323374388
Neurosci18667048013170123181212269309357379
Lett.22697048013149101134171190
1990;2483704801315398152206225
116(1–2):2732704801315494141169216266313339356
184–189.31127048013154100155212258305357372
17.6247196013356104115
Abrams7607196013367129165218309351
P,1132719601335968
Andersson12217196013367127189244280324367427488
KE,17297196013360115137
Buccafusco18877196013360120169217270301362405454513
JJ,2420719601334180101
et2542719601335592
al.2654719601335379101
Muscarinic27767198013186143182231281312335392414462
receptors:3260719801313284133184244276332364405423
their3704719801313492145167198
distribution3924719801316081120155187209269327360382440499
and44447198013150108167
function4632719801312988146194231253310369
in5022719801312381
body6247348013161120180229
systems,877734801314190130165216305344363
and12647348013150108167
the1455734801313492146
implications16257348013123111171194215264313346368425484523
for2172734801312986118
treating2314734801313466118166198220278337
overactive26757348013159107159190240289325347396448
bladder.3147734801316184132192251304336350
Br3521734801315587
J36327348013138
Pharmacol.36947348013155112161192282331380435459477
2006;41957348013154105160215232
148(5):44517348013154100155183234260277
565–78.47527348013154106157212260310329
18.6247496013356107130
Duong7817496013374134195255317
V,1125749601336177
Iwamoto12307496013326106159250310346405
A,1662749601336892
Pennycuff17827496013358111172232281329389421453
J,2262749601334162
Kudish23527496013359118180205247308
B,2687749601336082
Iglesia2796749601332788114168211236288
C.3112749601336388
A32287498013164
systematic3321749801314190130165216305354386408456
review3806749801313284132155208286
of4120749801315987
neurocognitive42367498013159112169200257306362423480502535557607659
dys‑49237498013160108148179
function624764801312988146194230252310369
with10177648013179102135193
overactive12347648013159107159190240289325347396448
bladder1706764801316184133192251304336
medications.20667648013190143203225273323355377435494533553
Int2643764801312381112
Urogynecol27797648013169100157217265325378427483506
J.3309764801313856
2021;33897648013154105155202212
32(10):36257648013154103128176223250266
2693–2702.39157648013154105156206261308358408457475